Aug 14, 2026Amended0001520138-26-000350
All companies
424B4Sep 18, 2020
BI
Biovie Inc
BIVIPublicArchived
Public / ArchivedUnited States(Nasdaq)Best valuation $19.27M1 market
Public listing
Listed· Nasdaq· Listing market: United StatesListing date
Not available
Offer price
Not available
Shares offered
Not available
Offering proceeds
Not available
Sources: sec-edgar, sec-harvest, nasdaq
IPO Calendar · NasdaqIPO
BIVIPrice
$2.28
24h
+5.56%
Valuation
$19.27M
24h volume
$3.54M
Type
IPO
IPO Calendar · updated 58m ago
Biovie Inc IPO public float & lock-up
Public float and locked shares extracted from Biovie Inc's SEC prospectus. Shares shown are eligible to trade — lock-up expiry does not mean holders have sold or will sell.
Total shares (FD)
13.58M
Public float
—
Locked
—
IPO raise
—
Next unlock
—
Needs review: Could not extract a detailed lock-up release schedule.
Financials
UnprofitableFrom SEC filings, latest FY ending Jun 30, 2026 · CIK 0001580149.
Revenue
—
Net income
-$22.07M
Gross margin
—
Cash
$8.98M
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating income | -$22.65M | -$18.07M | -$32.18M | -$45.08M | -$27.25M |
| Net income | -$22.07M | -$17.54M | -$32.12M | -$50.26M | -$26.08M |
| R&D expense | $13.96M | $9.27M | $23.1M | $33.3M | $17.26M |
| Cash & equivalents | $8.98M | $17.54M | $23.84M | $19.46M | $18.64M |
| Total assets | $14.25M | $21.56M | $25.21M | $35.1M | $20.11M |
| Total liabilities | $3.98M | $2.55M | $9.7M | $19.76M | $16.44M |
| Shareholders' equity | $10.27M | $19.01M | $15.51M | $15.34M | $3.67M |
SEC IPO filings
AmendedEDGAR filings resolved from BIVI / CIK 0001580149.
Aug 7, 2026Free writing prospectus0001520138-26-000324
Aug 6, 2026Free writing prospectus0001520138-26-000320
Aug 6, 2026Free writing prospectus0001520138-26-000314
Aug 6, 2026Amended0001520138-26-000313
Jul 31, 2026Amended0001520138-26-000299
Jul 17, 2026Filed0001520138-26-000276
Jun 29, 2026Effective9999999995-26-002154
Jun 11, 2026Confidential draft0001520138-26-000230
Nov 18, 2025Effective9999999995-25-003311
Oct 6, 2025Final prospectus0001520138-25-000292
Aug 7, 2025Effective9999999995-25-002514
Biovie Inc IPO — frequently asked questions
- When did Biovie Inc go public?
- Biovie Inc has already gone public and now trades publicly on Nasdaq under the ticker BIVI.
- Can I buy Biovie Inc stock?
- Yes — Biovie Inc is publicly traded on Nasdaq as BIVI. You can follow its live price, valuation and post-IPO performance above.
- What is Biovie Inc's valuation?
- Biovie Inc's most recent valuation tracked here is $19.27M, derived from live market prices.